Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S158-S190
Open Access | Times Cited: 327

Showing 1-25 of 327 citing articles:

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
A. Michael Lincoff, Kirstine Brown‐Frandsen, Helen M. Colhoun, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 24, pp. 2221-2232
Open Access | Times Cited: 1034
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 856
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
Chiadi E. Ndumele, Janani Rangaswami, Sheryl L. Chow, et al.
Circulation (2023) Vol. 148, Iss. 20, pp. 1606-1635
Open Access | Times Cited: 369
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Wah‐Kheong Chan, Kee Huat Chuah, Ruveena Bhavani Rajaram, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 3, pp. 197-213
Open Access | Times Cited: 251
2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction
M. Kittleson, Gurusher Panjrath, Kaushik Amancherla, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 18, pp. 1835-1878
Open Access | Times Cited: 232
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
Chiadi E. Ndumele, Ian J. Neeland, Katherine R. Tuttle, et al.
Circulation (2023) Vol. 148, Iss. 20, pp. 1636-1664
Open Access | Times Cited: 226
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association
Sadiya S. Khan, Josef Coresh, Michael Pencina, et al.
Circulation (2023) Vol. 148, Iss. 24, pp. 1982-2004
Closed Access | Times Cited: 179
Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention
Nathan D. Wong, Naveed Sattar
Nature Reviews Cardiology (2023) Vol. 20, Iss. 10, pp. 685-695
Closed Access | Times Cited: 175
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, et al.
Diabetes & Metabolism Journal (2023) Vol. 47, Iss. 5, pp. 575-594
Open Access | Times Cited: 75
Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study
Kyung‐Soo Kim, Sangmo Hong, Kyungdo Han, et al.
BMJ (2024), pp. e076388-e076388
Open Access | Times Cited: 57
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes
Neha J. Pagidipati, Adam J. Nelson, Lisa A. Kaltenbach, et al.
JAMA (2023) Vol. 329, Iss. 15, pp. 1261-1261
Open Access | Times Cited: 56
Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes: Contemporary Understanding With Greater Emphasis on Excess Adiposity
Naveed Sattar, Calum Presslie, Martin K. Rutter, et al.
Diabetes Care (2024) Vol. 47, Iss. 4, pp. 531-543
Open Access | Times Cited: 18
Prevention of Cardiovascular Disease in Type 1 Diabetes
Camila Manrique‐Acevedo, Irl B. Hirsch, Robert H. Eckel
New England Journal of Medicine (2024) Vol. 390, Iss. 13, pp. 1207-1217
Closed Access | Times Cited: 16
GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage
Brady Park, Ehab Bakbak, Hwee Teoh, et al.
AJP Heart and Circulatory Physiology (2024) Vol. 326, Iss. 5, pp. H1159-H1176
Closed Access | Times Cited: 15
The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer
Robert Fitridge, Vivienne Chuter, Joseph L. Mills, et al.
Diabetes/Metabolism Research and Reviews (2023) Vol. 40, Iss. 3
Open Access | Times Cited: 40
Steatotic liver disease, MASLD and risk of chronic kidney disease
Josh Bilson, Alessandro Mantovani, Christopher D. Byrne, et al.
Diabetes & Metabolism (2023) Vol. 50, Iss. 1, pp. 101506-101506
Open Access | Times Cited: 33
Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023
Harold Bays, Shagun Bindlish, Tiffany Lowe Clayton
Obesity Pillars (2023) Vol. 5, pp. 100056-100056
Open Access | Times Cited: 32
Cardiorenal benefits of finerenone: protecting kidney and heart
José Ramón González–Juanatey, José Luis Górriz, Alberto Ortíz, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 502-513
Open Access | Times Cited: 32
Amlodipine in the current management of hypertension
Ji‐Guang Wang, Biff F. Palmer, Katherine Vogel Anderson, et al.
Journal of Clinical Hypertension (2023) Vol. 25, Iss. 9, pp. 801-807
Open Access | Times Cited: 32
The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer
Robert Fitridge, Vivienne Chuter, Joseph L. Mills, et al.
Journal of Vascular Surgery (2023) Vol. 78, Iss. 5, pp. 1101-1131
Open Access | Times Cited: 31
Biomarkers to Guide Medical Therapy in Primary Aldosteronism
Gregory L. Hundemer, Alexander A. C. Leung, Gregory Kline, et al.
Endocrine Reviews (2023) Vol. 45, Iss. 1, pp. 69-94
Open Access | Times Cited: 26
Editor's Choice – The Intersocietal IWGDF, ESVS, SVS Guidelines on Peripheral Artery Disease in People With Diabetes Mellitus and a Foot Ulcer
Robert Fitridge, Vivienne Chuter, Joseph L. Mills, et al.
European Journal of Vascular and Endovascular Surgery (2023) Vol. 66, Iss. 4, pp. 454-483
Open Access | Times Cited: 26
Once‐weekly semaglutide use in patients with type 2 diabetes: Real‐world data from the SURE Italy observational study
Raffaele Napoli, Cesare Berra, Andrei‐Mircea Catarig, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 6, pp. 1658-1667
Open Access | Times Cited: 24
Common metabolic features of hypertension and type 2 diabetes
Isao Usui
Hypertension Research (2023) Vol. 46, Iss. 5, pp. 1227-1233
Closed Access | Times Cited: 24
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
О. М. Драпкина, А. V. Kontsevaya, А. М. Калинина, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2024) Vol. 23, Iss. 3, pp. 3696-3696
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top